ResMed Return on Tangible Equity 2010-2023 | RMD
Current and historical return on tangible equity values for ResMed (RMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ResMed Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $0.89B | $1.09B | 106.29% |
| 2023-09-30 | $0.91B | $0.88B | 137.16% |
| 2023-06-30 | $0.90B | $0.81B | 122.76% |
| 2023-03-31 | $0.86B | $0.58B | 107.98% |
| 2022-12-31 | $0.81B | $0.38B | 90.01% |
| 2022-09-30 | $0.79B | $1.16B | 77.96% |
| 2022-06-30 | $0.78B | $1.08B | 86.52% |
| 2022-03-31 | $0.78B | $0.98B | 100.87% |
| 2021-12-31 | $0.52B | $0.82B | 84.02% |
| 2021-09-30 | $0.50B | $0.73B | 90.72% |
| 2021-06-30 | $0.48B | $0.57B | 104.05% |
| 2021-03-31 | $0.46B | $0.37B | 129.01% |
| 2020-12-31 | $0.70B | $0.54B | 293.39% |
| 2020-09-30 | $0.68B | $0.35B | 852.66% |
| 2020-06-30 | $0.62B | $0.16B | -946.01% |
| 2020-03-31 | $0.51B | $-0.09B | -281.87% |
| 2019-12-31 | $0.46B | $-0.09B | -170.25% |
| 2019-09-30 | $0.42B | $-0.24B | -132.59% |
| 2019-06-30 | $0.41B | $-0.31B | -288.26% |
| 2019-03-31 | $0.45B | $-0.43B | 343.74% |
| 2018-12-31 | $0.45B | $-0.29B | 105.44% |
| 2018-09-30 | $0.34B | $0.47B | 49.72% |
| 2018-06-30 | $0.32B | $0.78B | 42.66% |
| 2018-03-31 | $0.31B | $0.76B | 43.66% |
| 2017-12-31 | $0.29B | $0.70B | 43.98% |
| 2017-09-30 | $0.35B | $0.73B | 61.79% |
| 2017-06-30 | $0.34B | $0.63B | 69.33% |
| 2017-03-31 | $0.32B | $0.54B | 77.10% |
| 2016-12-31 | $0.33B | $0.39B | 58.26% |
| 2016-09-30 | $0.35B | $0.42B | 47.48% |
| 2016-06-30 | $0.35B | $0.34B | 38.68% |
| 2016-03-31 | $0.36B | $1.10B | 31.11% |
| 2015-12-31 | $0.36B | $1.06B | 30.24% |
| 2015-09-30 | $0.35B | $1.16B | 28.55% |
| 2015-06-30 | $0.35B | $1.28B | 27.58% |
| 2015-03-31 | $0.35B | $1.23B | 26.87% |
| 2014-12-31 | $0.35B | $1.27B | 26.20% |
| 2014-09-30 | $0.35B | $1.33B | 25.73% |
| 2014-06-30 | $0.35B | $1.42B | 25.44% |
| 2014-03-31 | $0.33B | $1.35B | 24.97% |
| 2013-12-31 | $0.33B | $1.30B | 24.20% |
| 2013-09-30 | $0.32B | $1.36B | 23.05% |
| 2013-06-30 | $0.31B | $1.29B | 22.30% |
| 2013-03-31 | $0.31B | $1.44B | 22.55% |
| 2012-12-31 | $0.29B | $1.41B | 21.72% |
| 2012-09-30 | $0.28B | $1.37B | 21.30% |
| 2012-06-30 | $0.26B | $1.30B | 20.34% |
| 2012-03-31 | $0.24B | $1.28B | 18.29% |
| 2011-12-31 | $0.23B | $1.24B | 17.03% |
| 2011-09-30 | $0.22B | $1.22B | 16.33% |
| 2011-06-30 | $0.23B | $1.45B | 16.82% |
| 2011-03-31 | $0.22B | $1.38B | 17.73% |
| 2010-12-31 | $0.22B | $1.34B | 18.53% |
| 2010-09-30 | $0.21B | $1.21B | 18.91% |
| 2010-06-30 | $0.19B | $1.06B | 18.64% |
| 2010-03-31 | $0.18B | $1.08B | 18.73% |
| 2009-12-31 | $0.17B | $0.99B | 19.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $26.307B | $4.223B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
| Stryker (SYK) | United States | $123.816B | 30.70 |
| Medtronic (MDT) | Ireland | $105.535B | 14.94 |
| Boston Scientific (BSX) | United States | $98.780B | 32.84 |
| EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
| Terumo (TRUMY) | Japan | $24.492B | 34.59 |
| Baxter (BAX) | United States | $20.044B | 14.62 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.641B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
| Demant (WILYY) | Denmark | $9.965B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
| BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
| Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
| Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
| Haemonetics (HAE) | United States | $4.126B | 21.10 |
| GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
| Envista Holdings (NVST) | United States | $3.430B | 13.05 |
| QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
| Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
| Neogen (NEOG) | United States | $2.515B | 24.19 |
| ICU Medical (ICUI) | United States | $2.333B | 17.41 |
| TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
| Owens & Minor (OMI) | United States | $1.899B | 18.23 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
| InMode (INMD) | Israel | $1.462B | 7.57 |
| LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
| AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
| Warby Parker (WRBY) | United States | $1.185B | 0.00 |
| AtriCure (ATRC) | United States | $1.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.977B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
| Evolus (EOLS) | United States | $0.668B | 0.00 |
| Quanterix (QTRX) | United States | $0.605B | 0.00 |
| Jin Medical (ZJYL) | China | $0.600B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
| Valneva SE (VALN) | France | $0.528B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
| PetIQ (PETQ) | United States | $0.479B | 17.89 |
| ZimVie (ZIMV) | United States | $0.420B | 25.72 |
| Biote (BTMD) | United States | $0.413B | 3.93 |
| OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
| Surmodics (SRDX) | United States | $0.377B | 40.75 |
| Zynex (ZYXI) | United States | $0.366B | 42.15 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Veru (VERU) | United States | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
| Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.091B | 0.00 |
| Brainsway (BWAY) | Israel | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.30 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |